Trial | NCT02912533  Report issue

Title

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    None
The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).
Study Started
Sep 30
2016
Primary Completion
Mar 31
2018
Study Completion
Mar 31
2018
Last Update
Apr 02
2019

Drug JR-131

JR-131 Experimental

Criteria 

Inclusion Criteria:

Patients being treated with erythropoiesis stimulating agent.

Exclusion Criteria:

Patients having complication or history of a cardiovascular / lung / brain infarction.
Patients having a pronounced hemorrhagic lesion.
No Results Posted